FINWIRES · TerminalLIVE
FINWIRES

Chardan Downgrades Tenax Therapeutics to Neutral From Buy, Adjusts Price Target to $5 From $27

By

Tenax Therapeutics (TENX) has an average rating of buy and mean price target of $14.78, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Price: $1.70, Change: $+0.32, Percent Change: +23.27%

Related Articles